GR-73632
|
|
|
- CAS号:
- 133156-06-6
- 英文名:
- DELTA-AMINOVALERYL-PHE-PHE-PRO-N-ME-LEU-MET-NH2
- 英文别名:
- GR 73632;GR-73632
(GR73632);H2H-(CH2)4-CO-PHE-PRO-NME-LEU-MET-NH2;d-AMinovaleryl-Phe-Phe-Pro-N-Me-Leu-Met-NH2;DELTA-AMINOVALERYL-PHE-PHE-PRO-N-ME-LEU-MET-NH2;d-AMinovaleryl-(Pro9,N-Me-Leu10)-Substance P (7-11);δ-Aminovaleryl-(Pro9,N-Me-Leu10)-Substance P (7-11);DELTA-AMINOVALERYL-(PRO9,N-ME-LEU10)-SUBSTANCE P (7-11);(DELTA-AMINOVALERYL6,PRO9,N-ME-LEU10)-SUBSTANCE P (6-11);δ-Aminovaleryl-[Pro9, Leu(N-Me)10]-SubstanceP Fragment 7-11
- 中文名:
- GR-73632
- 中文别名:
- 化合物GR-73632
- CBNumber:
- CB3126730
- 分子式:
- C40H59N7O6S
- 分子量:
- 766
- MOL File:
- 133156-06-6.mol
|
|
|
GR-73632化学性质
-
沸点:
-
1082.2±65.0 °C(Predicted)
-
|
-
密度:
-
1.198±0.06 g/cm3(Predicted)
-
|
-
储存条件:
-
-20°C
-
|
-
溶解度:
-
Water:1.0(Max Conc. mg/mL);1.31(Max Conc. mM)
-
|
-
形态:
-
Powder
-
|
-
酸度系数(pKa):
-
13.34±0.46(Predicted)
-
|
-
颜色:
-
White to off-white
-
|
-
水溶解性:
-
Soluble to 1 mg/ml in water
-
|
GR-73632性质、用途与生产工艺
GR-73632 是新型速激肽神经激肽1 (NK-1) 受体激动剂。
GR-73632 通过传递瘙痒信号的 NK1 受体直接作用于初级感觉神经元的外周末端。
GR-73632
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/04/30 | HY-P1192 | GR-73632 | | 1 mg | 4000元 |
133156-06-6, GR-73632 相关搜索:
- Tachykinins
- Peptides for Cell Biology
- Neuropeptides
- AgonistPeptides for Cell Biology
- 多肽
- 标准品
- BioChemical
- Amino Acids and Peptides
- Agonist
- Biochemicals and Reagents
- Tachykinins
- Peptides
- C40H59N7O6S
- 化合物GR-73632
- 133156-06-6
- Neurokinin Receptor,NK receptor,Tachykinin receptor,GR73632,inhibit,Inhibitor,GR-73632,GR 73632
- δ-Aminovaleryl-(Pro9,N-Me-Leu10)-Substance P (7-11)
- GR-73632
(GR73632)
- L-Methioninamide,N-(5-amino-1-oxopentyl)-L-phenylalanyl-L-phenylalanyl-L-prolyl-N-methyl-L-leucyl-
- DELTA-AMINOVALERYL-(PRO9,N-ME-LEU10)-SUBSTANCE P (7-11)
- DELTA-AMINOVALERYL-PHE-PHE-PRO-N-ME-LEU-MET-NH2
- (DELTA-AMINOVALERYL6,PRO9,N-ME-LEU10)-SUBSTANCE P (6-11)
- H2H-(CH2)4-CO-PHE-PRO-NME-LEU-MET-NH2
- GR 73632
- d-AMinovaleryl-Phe-Phe-Pro-N-Me-Leu-Met-NH2
- d-AMinovaleryl-(Pro9,N-Me-Leu10)-Substance P (7-11)
- (2S)-N-[(2S)-1-[[(2S)-1-azanyl-4-methylsulfanyl-1-oxo-butan-2-yl]amino]-4-methyl-1-oxo-pentan-2-yl]-1-[(2S)-2-[[(2S)-2-(5-azanylpentanoylamino)-3-phenyl-propanoyl]amino]-3-phenyl-propanoyl]-N-methyl-pyrrolidine-2-carboxamide
- (2S)-N-[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-1-[(2S)-2-[[(2S)-2-(5-aminopentanoylamino)-3-phenylpropanoyl]amino]-3-phenylpropanoyl]-N-methylpyrrolidine-2-carboxamide
- (2S)-1-[(2S)-2-[[(2S)-2-(5-aminopentanoylamino)-3-phenyl-propanoyl]amino]-3-phenyl-propanoyl]-N-[(1S)-1-[[(1S)-1-carbamoyl-3-(methylthio)propyl]carbamoyl]-3-methyl-butyl]-N-methyl-pyrrolidine-2-carboxamide
- N-(5-Amino-1-oxopentyl)-L-Phe-L-Phe-L-Pro-N-methyl-L-Leu-L-Met-NH2
- δ-Aminovaleryl-[Pro9, Leu(N-Me)10]-SubstanceP Fragment 7-11